Searched for
ALEMBIC PHARMA RESULTS
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Stocks in news: Adani Enterprises, Tata Motors PV, Tata Steel, Jio Financial, ITC HotelsMarkets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- Stocks in news: Tata Investment, Narayana Hrudalaya, Hero MotoCorp, Bharti Airtel, Alembic PharmaEquity markets experienced pressure on monthly expiry day, slipping nearly half a percent. Shares of Tata Investment, Narayana Hrudalaya, H...
- Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 croreEarnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540...
- Alembic Pharma posts Rs 180 crore net profit in Q3FY24Drug maker Alembic Pharma on Monday reported Rs 180 crore net profit in Q3FY24, which is a 48% year-on-year (YoY) increase compared to the ...
- Alembic Pharma Q2 Results: Firm posts Rs 137-crore net profitRevenues grew 8% to Rs.1595 crore in Q2FY24 compared to Rs 1475 crore last year. The earnings before interest, tax, depreciation and amorti...
- Manufacturing operations disrupted at Sikkim plant due to flash floods: Alembic PharmaFlash floods in the Teesta River has led to disruption in operations at its Sikkim-based manufacturing plant, said Alembic Pharmaceuticals ...
- Alembic Pharma Q1 Results: Firm posts profit on strong salesThe Vadodara-based company said consolidated profit rose to 1.21 billion rupees ($14.6 million) for the quarter ended June 30 from a loss o...
- Alembic Pharma's revival on the cards: Why it is stock pick of the weekAlembic Pharma is looking forward to high growth with API and RoW businesses reporting decent growth. Besides, new products in pipeline and...
- Alembic Pharma arm gets tentative USFDA nod for drug to treat pulmonary arterial hypertensionAlembic Global Holdings SA has received tentative approval from the US Food and Drug Administration for its abbreviated new drug applicatio...
- Alembic Pharma Q4 results: Net profit up 81% to Rs 225 croreThe company had posted a net profit of Rs 124 crore for the corresponding period of the previous fiscal.
- Alembic Pharma Q3 profit up 30% at Rs 170 croreRevenue from operations stood at Rs 1,018.15 crore in the reported quarter as against Rs 840.02 crore.
- Alembic Pharma Q2 profit up 64 % to Rs 200 croreInternational formulations sales grew to Rs 587 crore from Rs 262 crore in the year-ago period, the company said.
- Stock pick of the week: What makes Alembic Pharma a good bet in muted pharma industryInvestment in R&D and new facilities focus on exports, new launches and likely growth in revenue of about 35% in the coming years has made ...
- Alembic Pharma: Further re-rating likely due to high growth rate, strong balance sheetAfter remaining on the sidelines for a decade, Alembic Pharma’s stock has been in the limelight in the recent past.
- Alembic Pharmaceuticals outshines pharma peers as new drugs spur growth100-year-old Vadodara-based firm, Alembic Pharmaceuticals is the second-best pharma stock in the BSE 500 in the past one year.
- Alembic Pharma will add more specialty product, Q2 net profit up 12%Alembic Pharmaceuticals posts 12% rise in Q2 net profit. Will add more to the basket of specialty products for growth.
- Alembic Pharma sales up 34%, plans Brazil forayAlembic Pharmaceuticals has posted 34% rise in net sales in its first quarter result after being carved out of Alembic Ltd.
Load More
